However, there was no association between plasma RANKL and breast cancer risk when stratified into high vs. low plasma RANKL levels (HR = 1.06; 95% CI 0.34–3.28; p = 0.86) [45]. This evidence concerns the gene TNFSF11 and breast cancer.